27 November 2019
Positive Data for RECCE® 327 in MRSA Burns Wound Infection
20 November 2019
Forbion Wins “VC firm of the Year” at the LSX’s LifeStars Awards
19 November 2019
Microbiotica relocates to Chesterford Research Park, Cambridge
10 October 2019
Recce Completes Raising of $6.76 million
02 October 2019
Congenica Integrates Powerful New Curated Data
25 September 2019
HOOKIPA Announces Key Hires to its Executive Team
20 September 2019
Key Family 2 Patent Granted in Japan for RECCE® Antibiotics
26 July 2019
BleepaTM – revolutionising clinical messaging
16 July 2019
Clinigen: Year end trading update
10 July 2019
Outcome of strategic review and trading update
04 July 2019
Business Update and Board Changes
30 April 2019
Biotec Pharmacon Q1 2019 Results
18 April 2019
SkinBioTherapeutics plc: Director Appointment
08 April 2019
SkinBiotix® shows efficacy in first human study
29 March 2019
SkinBioTherapeutics plc: CEO Designate Appointment
14 March 2019
USA Patent Granted for Recce's Antibiotics
27 February 2019
Abcam moves to new purpose-built global headquarters
15 February 2019
HOOKIPA Appoints Michael A. Kelly as Independent Director
14 February 2019
SkinBioTherapeutics Half Year Results
05 February 2019
Nick Keher appointed CFO of Clinigen Group
30 January 2019
Biotec Pharmacon Q4 2018 Results
29 January 2019
Biotec Pharmacon finalises Post Market study on Woulgan®
28 January 2019
Microbiotica Presenting at Key Microbiome Events in Q1 2019
24 January 2019
Feedback plc Half Year Result
15 January 2019
Clinigen Half Year trading update